Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2988)
All Articles published online
|
Jan 7, 2006 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen XH, Lan B, Qu Y, Zhang XQ, Cai Q, Liu BY, Zhu ZG. Inhibitory effect of Polo-like kinase 1 depletion on mitosis and apoptosis of gastric cancer cells. World J Gastroenterol 2006; 12(1): 29-35 [PMID: 16440413 DOI: 10.3748/wjg.v12.i1.29] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i1/29.htm |
| Number | Citing Articles |
| 1 |
Timothy J. Lansing, Randy T. McConnell, Derek R. Duckett, Glenn M. Spehar, Victoria B. Knick, Daniel F. Hassler, Nobuhiro Noro, Masaaki Furuta, Kyle A. Emmitte, Tona M. Gilmer, Robert A. Mook, Mui Cheung.
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Molecular Cancer Therapeutics 2007; 6(2): 450 doi: 10.1158/1535-7163.MCT-06-0543
|
| 2 |
Zi-Li He, He Zheng, Hui Lin, Xiong-Ying Miao, De-Wu Zhong. Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients. World Journal of Gastroenterology 2009; 15(33): 4177-4182 doi: 10.3748/wjg.15.4177
|
| 3 |
正伟 杨. Integrating Multiple Omics Data to Search for Driver Genes for Gastric Cancer. Computer Science and Application 2020; 10(10): 1820 doi: 10.12677/CSA.2020.1010192
|
| 4 |
Denise L. Driscoll, Arijit Chakravarty, Doug Bowman, Vaishali Shinde, Kerri Lasky, Judy Shi, Tricia Vos, Bradley Stringer, Ben Amidon, Natalie D'Amore, Marc L. Hyer, Benjamin Edward Rich. Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines. PLoS ONE 2014; 9(11): e111060 doi: 10.1371/journal.pone.0111060
|
| 5 |
Ding-pei Han, Qian-lin Zhu, Jiang-tao Cui, Pu-xiongzhi Wang, Shun Qu, Qi-feng Cao, Ya-ping Zong, Bo Feng, Min-hua Zheng, Ai-guo Lu. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells. Medical Science Monitor 2012; 18(6): BR237 doi: 10.12659/MSM.882900
|
| 6 |
Ion Cristóbal, Federico Rojo, Juan Madoz-Gúrpide, Jesús García-Foncillas. Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications. Molecular and Cellular Biology 2016; 36(12): 1734 doi: 10.1128/MCB.00130-16
|
| 7 |
Peng Lin, Dan-Dan Xiong, Yi-Wu Dang, Hong Yang, Yun He, Dong-Yue Wen, Xin-Gan Qin, Gang Chen. The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation. Oncotarget 2017; 8(54): 92497 doi: 10.18632/oncotarget.21438
|
| 8 |
Mao-Wei Cheng, Bing-Chan Wang, Zhi-Qiang Weng, Xiao-Wei Zhu. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma. Acta Histochemica 2012; 114(5): 503 doi: 10.1016/j.acthis.2011.09.004
|
| 9 |
Sung-Min Kim, Sunmi Yoon, Naeun Choi, Kwan Soo Hong, Ravichandran N. Murugan, Gyunggoo Cho, Eun Kyoung Ryu. In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide. Biomaterials 2012; 33(29): 6915 doi: 10.1016/j.biomaterials.2012.06.046
|
| 10 |
Shilpa Tyagi, Kulpreet Bhui, Richa Singh, Madhulika Singh, Sheikh Raisuddin, Yogeshwer Shukla. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells. Biochemical Pharmacology 2010; 80(9): 1326 doi: 10.1016/j.bcp.2010.07.025
|
| 11 |
Furan Song, Naoyuki Sakurai, Ayaka Okamoto, Hiroyuki Koide, Naoto Oku, Takehisa Dewa, Tomohiro Asai. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors. Biological and Pharmaceutical Bulletin 2019; 42(6): 996 doi: 10.1248/bpb.b19-00032
|